FL Meyskens

578 total citations
21 papers, 403 citations indexed

About

FL Meyskens is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, FL Meyskens has authored 21 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in FL Meyskens's work include Melanoma and MAPK Pathways (6 papers), melanin and skin pigmentation (4 papers) and Retinoids in leukemia and cellular processes (4 papers). FL Meyskens is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), melanin and skin pigmentation (4 papers) and Retinoids in leukemia and cellular processes (4 papers). FL Meyskens collaborates with scholars based in United States and Germany. FL Meyskens's co-authors include H S Garewal, A. Donny Strosberg, D. S. Reeves, David King, Karen Steinbronn, Theodore A. Kiersch, M. Graham, Charles W. Taylor, Ralph J. Tuthill and E. M. Hersh and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cell Death and Differentiation.

In The Last Decade

FL Meyskens

21 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
FL Meyskens United States 8 174 102 88 69 60 21 403
Lakshmi Krishnamoorthy India 13 210 1.2× 75 0.7× 20 0.2× 14 0.2× 13 0.2× 30 469
Edward P. Retzbach United States 8 116 0.7× 139 1.4× 9 0.1× 49 0.7× 17 0.3× 12 289
Hyae‐Gyeong Cheon South Korea 6 197 1.1× 52 0.5× 11 0.1× 37 0.5× 9 0.1× 7 401
Stefano Monteghirfo Italy 8 184 1.1× 83 0.8× 24 0.3× 61 0.9× 27 0.5× 12 342
J. De Bersaques Belgium 10 125 0.7× 41 0.4× 5 0.1× 33 0.5× 14 0.2× 49 342
Xiaoyan Gu China 14 373 2.1× 49 0.5× 7 0.1× 66 1.0× 34 0.6× 28 565
Danute Butkus United States 5 416 2.4× 34 0.3× 84 1.0× 93 1.3× 37 0.6× 5 750
Fang‐Wei Hu Taiwan 11 270 1.6× 184 1.8× 14 0.2× 33 0.5× 39 0.7× 12 469
Tiago Henrique Brazil 12 207 1.2× 101 1.0× 5 0.1× 57 0.8× 13 0.2× 25 429
Nasta Tanić Serbia 11 187 1.1× 103 1.0× 10 0.1× 19 0.3× 12 0.2× 28 342

Countries citing papers authored by FL Meyskens

Since Specialization
Citations

This map shows the geographic impact of FL Meyskens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FL Meyskens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FL Meyskens more than expected).

Fields of papers citing papers by FL Meyskens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FL Meyskens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FL Meyskens. The network helps show where FL Meyskens may publish in the future.

Co-authorship network of co-authors of FL Meyskens

This figure shows the co-authorship network connecting the top 25 collaborators of FL Meyskens. A scholar is included among the top collaborators of FL Meyskens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FL Meyskens. FL Meyskens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kasuno, Kenji, Asma Naqvi, Jeremy DeRicco, et al.. (2007). Antagonism of p66shc by melanoma inhibitory activity. Cell Death and Differentiation. 14(8). 1414–1421. 7 indexed citations
2.
Elmore, Eugene, et al.. (2006). Response of rosiglitazone, UAB 30, and atorvastatin in the human melanoma prevention assayl.. In Vitro Cellular & Developmental Biology - Animal. 42. 1 indexed citations
3.
Meyskens, FL, Shirley Gidanian, & Patrick J. Farmer. (2006). Pro-Oxidant Properties of Melanosomal Melanin from Melanoma Origin. eScholarship (California Digital Library). 41. 2 indexed citations
4.
Meyskens, FL, et al.. (2006). New perspectives on melanoma pathogenesis and chemoprevention. European Journal of Cancer Supplements. 4(1). 26–26. 2 indexed citations
5.
Yang, Seung-Ju & FL Meyskens. (2004). Resveratrol induces AP-1 inhibition, altered AP-1 composition and increased expression of specific jun and fos family proteins in human Melanoma cells.. Pigment Cell Research. 17(4). 445–445. 1 indexed citations
6.
Cen, Dazhi, Daniel F. Brayton, Babbak Shahandeh, et al.. (2004). Disulfiram facilitates intracellular copper transport that causes Oxidative stress and cell death in human Melanoma cells.. Pigment Cell Research. 17(4). 444–445. 1 indexed citations
7.
Meyskens, FL, Marianne Gerber, F. de Waard, et al.. (2000). WHO consensus conference on diet and cancer. European Journal of Cancer Prevention. 9(3). 213–216. 4 indexed citations
8.
Meyskens, FL, M Gerber, F. de Waard, et al.. (2000). A regular contribution from Lars Ovesen, which we hope will help the busy scientist in keeping up with the literature. European Journal of Cancer Prevention. 9(3). 217–218. 3 indexed citations
9.
Meyskens, FL, et al.. (1996). Regulation of the redox-sensitive transcription factors NF-kB and AP-1 by ultraviolet light-B in human melanocytes. eScholarship (California Digital Library). 1096. 25–34. 1 indexed citations
10.
Omenn, Gilbert S., Mark Thornquist, Scott Barnhart, et al.. (1996). Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.. PubMed. 67–85. 36 indexed citations
11.
Meyskens, FL, Kenneth J. Kopecky, Charles W. Taylor, et al.. (1995). Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study. JNCI Journal of the National Cancer Institute. 87(22). 1710–1713. 83 indexed citations
12.
Moon, Thomas E., Norman Levine, Brenda Cartmel, et al.. (1995). Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group.. PubMed. 4(6). 661–9. 20 indexed citations
13.
Garewal, Harinder S., et al.. (1993). Oral Cancer Prevention: The Case for Carotenoids and Anti-Oxidant Nutrients. Preventive Medicine. 22(5). 701–711. 27 indexed citations
14.
Garewal, H S & FL Meyskens. (1993). Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal.. PubMed. 1(2). 155–9. 22 indexed citations
15.
Meyskens, FL, et al.. (1992). 180. Expression of the retinoic acid receptors and effect of retinoic acid on human primary neonatal melanocytes and metastatic melanoma cells strains. Biomedicine & Pharmacotherapy. 46(5-7). 330–330. 1 indexed citations
16.
McPherson, John D., et al.. (1991). CHROMOSOMAL LOCALIZATION OF MULTIPLE GENES ENCODING CALMODULIN. eScholarship (California Digital Library). 5 indexed citations
17.
Graham, M., et al.. (1991). The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis. 12(1). 105–109. 51 indexed citations
18.
Garewal, H S, FL Meyskens, D. S. Reeves, et al.. (1990). Response of oral leukoplakia to beta-carotene.. Journal of Clinical Oncology. 8(10). 1715–1720. 130 indexed citations
19.
McBride, Heyoung L., et al.. (1989). Chromosome alterations in 71 cases of malignant metastatic melanoma. Cancer Genetics and Cytogenetics. 41(2). 280–280. 1 indexed citations
20.
Meyskens, FL, et al.. (1982). AMSA therapy for children with lymphoblastic malignancy.. PubMed. 66(3). 593–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026